AGGF1, a protein that declines with age and hypertension, preserves blood vessel function by regulating SESN2 expression and reducing oxidative stress. This pathway offers a mechanistic target for intervening in age-related blood pressure elevation before it becomes established disease.
Key Points
- AGGF1 decline precedes hypertension; overexpression delays age-related pressure rise
- AGGF1 protects endothelial cells through SESN2-dependent reduction of senescence
- Mechanism involves oxidative stress suppression and preservation of vessel relaxation
Longevity Analysis
The endothelium's progressive dysfunction represents a convergence point where oxidative damage, cellular senescence, and inflammatory signaling accelerate vascular aging. AGGF1's protective effects operate upstream of these degenerative cascades, working through SESN2 to limit reactive oxygen species accumulation and senescent cell markers. Rather than treating established hypertension, this research identifies a molecular mechanism that could support the preservation of endothelial function during the prehypertensive window—the critical period before structural vascular changes become irreversible. Understanding how AGGF1 sustains this protective capacity creates potential intervention points at an earlier stage of disease progression.
Original published by LifeSpan.io, by Josh Conway.